ArticleJournal of thoracic disease2026

Radiotherapy combined with third-generation EGFR tyrosine kinase inhibitor in first-line treatment of advanced oligometastatic non-small cell lung cancer: a single-center, retrospective study.

Jianqingchen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.